Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaydeepbhai Patel

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|February 22, 2024
Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapyShenduo Li, Rami Manochakian, Ruqin Chen, et al.
Targeted Oncology|August 9, 2024
Identifying Actionable Alterations in KRAS Wild-Type Pancreatic CancerAhmed Elhariri, Jaydeepbhai Patel, Himil Mahadevia, et al.
Journal of Gastrointestinal Oncology|September 15, 2025
Stereotactic body radiation therapy in oligometastatic pancreatic cancer: overall survival improvement and <i>SMAD4</i> as a predictor of progression-free survivalAhmed Elhariri, Jaydeepbhai Patel, Himil Mahadevia, et al.
Experimental Neurology|June 17, 2026
Proteomics reveal PTEN as a critical mediator of sustained mitochondrial dysfunction during chronic spinal cord injurySamir P Patel, Carlos A Gartner, Mudjgiwa Patience, et al.
JAMA Network Open|September 12, 2025
Circulating Tumor DNA and Tissue Testing for Pancreatobiliary TumorsHimil Mahadevia, Umair Majeed, Jaydeepbhai Patel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|February 22, 2024
Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapyShenduo Li, Rami Manochakian, Ruqin Chen, et al.
Targeted Oncology|August 9, 2024
Identifying Actionable Alterations in KRAS Wild-Type Pancreatic CancerAhmed Elhariri, Jaydeepbhai Patel, Himil Mahadevia, et al.
Journal of Gastrointestinal Oncology|September 15, 2025
Stereotactic body radiation therapy in oligometastatic pancreatic cancer: overall survival improvement and <i>SMAD4</i> as a predictor of progression-free survivalAhmed Elhariri, Jaydeepbhai Patel, Himil Mahadevia, et al.
Experimental Neurology|June 17, 2026
Proteomics reveal PTEN as a critical mediator of sustained mitochondrial dysfunction during chronic spinal cord injurySamir P Patel, Carlos A Gartner, Mudjgiwa Patience, et al.
JAMA Network Open|September 12, 2025
Circulating Tumor DNA and Tissue Testing for Pancreatobiliary TumorsHimil Mahadevia, Umair Majeed, Jaydeepbhai Patel, et al.
Pageof 1